Frequently Asked Questions
The global molecular glues market was valued at USD 50.9 Million in 2022.
The molecular glues market is expected to grow at a CAGR of 9.50% between 2023 and 2030, reaching USD 96.08 Million in 2030.
PROteolysis Targeting Chimeras (PROTACs) is the leading segment by type, holding over 43% share in terms of value in 2022.
The cancer treatment segment governs the demand for molecular glues in the world, holding a massive share of over 80% in 2022.
The Contract Research Organizations (CROs) segment is expected to post the highest CAGR during the forecast period.
North America is fueling the growth of the molecular glues industry, with an over one-third share in 2022.
The top players include Proxygen GmbH, Tocris Bioscience, Lifesensors Inc., Evotec SE, Eli Lilly and Company, Bristol-Myers Squibb Company, C4 Therapeutics, Inc., Seed Therapeutics, Inc, Ranok Therapeutics Co.Ltd., Venquis Therapeutics, and Monte Rosa Therapeutics Inc.
the rising need for adhesives and the benefits offered by molecular glues are the major market drivers.
high product development costs and fluctuating worldwide raw material prices are the major market restraints.
Technology is advancing in the market for molecular superglue. The production of these molecular superglues is being worked on by businesses to find new and improved processes. The development of new techniques for making adhesives is expected to drive the growth of the molecular superglue market during the forecast period, and an increase in usage is the main opportunity in the molecular glues market.